Gentian Diagnostics Unveils Partnership to Develop New Diagnostic Assay

MT Newswires · 5d ago
05:05 AM EST, 01/07/2026 (MT Newswires) -- Gentian Diagnostics (GENT.OL) entered into an exclusive partnership with a global diagnostics company to develop a novel assay for a widely used clinical chemistry analyser platform. Under the deal, the Norwegian diagnostic test maker is responsible for assay development and will manufacture the devices upon commercialization, according to a Wednesday release. Commercial launch is expected in the second half of 2027, pending the completion of development and regulatory processes.